| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
First Department of Pathology [T. S., T. T., K. Y., H. N., H. I., E. T.] and First Department of Internal Medicine [T. S., K. H., G. K.], Hiroshima University School of Medicine, 1-2-3, Kasumi, Minami-ku, Hiroshima 734, and Division of Biochemistry, Cancer Institute, 1-37-1, Kami-Ikebukuro, Toshima-ku, Tokyo 170 [Y. N.], Japan
Recently, loss or inactivation of genes at specific chromosomal loci has been considered to be one of the important mechanisms during the development of human tumors. In order to identify tumor suppressor genes for gastric carcinoma, we performed restriction fragment length polymorphism analysis on 48 human gastric carcinomas. Allele losses were investigated for 14 specific loci on chromosomes 1, 5, 6, 7, 10, 11, 12, and 17. Loss of heterozygosity on chromosome 17p13.1 (p53 locus) was detected in 13 (68%) of 19 informative cases. Well-differentiated adenocarcinoma showed high frequencies of allele losses on chromosomes 5q (60%) and 17p (67%) in early cancers and on chromosomes 1q (67%), 5q (36%), 7p (33%), 7q (39%), and 17p (73%) in advanced cancers. In poorly differentiated adenocarcinomas, loss of heterozygosity was detected on chromosomes 1p (38%), 12q (31%), and 17p (60%). Allele losses on chromosomes 1q, 5q, and 7p were not detected in poorly differentiated adenocarcinoma, their frequencies being significantly different between the two histological types.
These results suggest that allele loss on chromosome 17p is a common event in gastric carcinoma, regardless of histological type, and that allele loss on chromosome 5q may play a role in the carcinogenesis of well-differentiated adenocarcinoma. Additionally, allele losses on chromosomes 1q and 7p may be involved in the progression of well-differentiated adenocarcinoma.
1 This work was supported in part by a Grant-in-Aid for a Comprehensive 10-Year Strategy for Cancer Control from the Ministry of Health and Welfare of Japan and in part by a Grant-in-Aid from the Ministry of Education, Science, and Culture of Japan.
2 To whom requests for reprints should be addressed.
Received 12/ 6/90. Accepted 3/13/91.
This article has been cited by other articles:
![]() |
A Gylling, W M Abdel-Rahman, M Juhola, K Nuorva, E Hautala, H J Jarvinen, J-P Mecklin, M Aarnio, and P Peltomaki Is gastric cancer part of the tumour spectrum of hereditary non-polyposis colorectal cancer? A molecular genetic study Gut, July 1, 2007; 56(7): 926 - 933. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Mutoh, S. Sakurai, K. Satoh, K. Tamada, H. Kita, H. Osawa, T. Tomiyama, Y. Sato, H. Yamamoto, N. Isoda, et al. Development of Gastric Carcinoma from Intestinal Metaplasia in Cdx2-transgenic Mice Cancer Res., November 1, 2004; 64(21): 7740 - 7747. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Kaneda, K. Wakazono, T. Tsukamoto, N. Watanabe, Y. Yagi, M. Tatematsu, M. Kaminishi, T. Sugimura, and T. Ushijima Lysyl Oxidase Is a Tumor Suppressor Gene Inactivated by Methylation and Loss of Heterozygosity in Human Gastric Cancers Cancer Res., September 15, 2004; 64(18): 6410 - 6415. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Suzuki, K. Egami, K. Sasajima, M. Ghazizadeh, H. Shimizu, H. Watanabe, H. Hasegawa, S. Iida, T. Matsuda, Y. Okihama, et al. Comparative Study between DNA Copy Number Aberrations Determined by Quantitative Microsatellite Analysis and Clinical Outcome in Patients with Stomach Cancer Clin. Cancer Res., May 1, 2004; 10(9): 3013 - 3019. [Abstract] [Full Text] [PDF] |
||||
![]() |
F Bataille, P Rummele, W Dietmaier, D Gaag, F Klebl, A Reichle, P Wild, F Hofstadter, and A Hartmann Alterations in p53 predict response to preoperative high dose chemotherapy in patients with gastric cancer Mol. Pathol., October 1, 2003; 56(5): 286 - 292. [Abstract] [Full Text] [PDF] |
||||
![]() |
B G Schneider, S Y Rha, H C Chung, J C Bravo, R Mera, J C Torres, K T Plaisance Jr, R Schlegel, C M McBride, X T Reveles, et al. Regions of allelic imbalance in the distal portion of chromosome 12q in gastric cancer Mol. Pathol., June 1, 2003; 56(3): 141 - 149. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Ott, H. Vogelsang, J. Mueller, K. Becker, M. Muller, U. Fink, J. R. Siewert, H. Hofler, and G. Keller Chromosomal Instability Rather Than p53 Mutation Is Associated with Response to Neoadjuvant Cisplatin-based Chemotherapy in Gastric Carcinoma Clin. Cancer Res., June 1, 2003; 9(6): 2307 - 2315. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Semba, N. Itoh, M. Ito, E. M. Youssef, M. Harada, T. Moriya, W. Kimura, and M. Yamakawa Down-Regulation of PIK3CG, a Catalytic Subunit of Phosphatidylinositol 3-OH Kinase, by CpG Hypermethylation in Human Colorectal Carcinoma Clin. Cancer Res., December 1, 2002; 8(12): 3824 - 3831. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. G. Fox, B. J. Sheppard, C. A. Dangler, M. T. Whary, M. Ihrig, and T. C. Wang Germ-Line p53-targeted Disruption Inhibits Helicobacter-induced Premalignant Lesions and Invasive Gastric Carcinoma through Down-Regulation of Th1 Proinflammatory Responses Cancer Res., February 1, 2002; 62(3): 696 - 702. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. P.A. Ebert, G. Fei, S. Kahmann, O. Muller, J. Yu, J. J.Y. Sung, and P. Malfertheiner Increased {beta}-catenin mRNA levels and mutational alterations of the APC and {beta}-catenin gene are present in intestinal-type gastric cancer Carcinogenesis, January 1, 2002; 23(1): 87 - 91. [Abstract] [Full Text] [PDF] |
||||
![]() |
D.-S. Byun, M.-G. Lee, K.-S. Chae, B.-G. Ryu, and S.-G. Chi Frequent Epigenetic Inactivation of RASSF1A by Aberrant Promoter Hypermethylation in Human Gastric Adenocarcinoma Cancer Res., October 1, 2001; 61(19): 7034 - 7038. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Terada, T. Yasutake, S. Nakamura, T. Hisamatsu, T. Nakagoe, H. Ayabe, and Y. Tagawa Evaluation of Metastatic Potential of Gastric Tumors by Staining for Proliferating Cell Nuclear Antigen and Chromosome 17 Numerical Aberrations Ann. Surg. Oncol., July 1, 2001; 8(6): 525 - 532. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Vecchione, H. Ishii, Y.-H. Shiao, F. Trapasso, M. Rugge, J. F. Tamburrino, Y. Murakumo, H. Alder, C. M. Croce, and R. Baffa Fez1/Lzts1 Alterations in Gastric Carcinoma Clin. Cancer Res., June 1, 2001; 7(6): 1546 - 1552. [Abstract] [Full Text] [PDF] |
||||
![]() |
E Hidaka, A Yanagisawa, M Seki, T Setoguchi, and Y Kato Genetic alterations and growth pattern in biliary duct carcinomas: loss of heterozygosity at chromosome 5q bears a close relation with polypoid growth Gut, May 1, 2001; 48(5): 656 - 659. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. H. Kim, N.-G. Kim, J. G. Lim, C. Park, and H. Kim Chromosomal Alterations in Paired Gastric Adenomas and Carcinomas Am. J. Pathol., February 1, 2001; 158(2): 655 - 662. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Grundei, H. Vogelsang, K. Ott, J. Mueller, M. Scholz, K. Becker, U. Fink, J. R. Siewert, H. Höfler, and G. Keller Loss of Heterozygosity and Microsatellite Instability as Predictive Markers for Neoadjuvant Treatment in Gastric Carcinoma Clin. Cancer Res., December 1, 2000; 6(12): 4782 - 4788. [Abstract] [Full Text] |
||||
![]() |
Y. Kitayama, H. Igarashi, and H. Sugimura Different Vulnerability among Chromosomes to Numerical Instability in Gastric Carcinogenesis: Stage-dependent Analysis by FISH with the Use of Microwave Irradiation Clin. Cancer Res., August 1, 2000; 6(8): 3139 - 3146. [Abstract] [Full Text] |
||||
![]() |
W. S. Park, R. R. Oh, J. Y. Park, S. H. Lee, M. S. Shin, Y. S. Kim, S. Y. Kim, H. K. Lee, P. J. Kim, S. T. Oh, et al. Frequent Somatic Mutations of the {beta}-Catenin Gene in Intestinal-Type Gastric Cancer Cancer Res., September 1, 1999; 59(17): 4257 - 4260. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. S. Yustein, J. C. Harper, G. R. Petroni, O. W. Cummings, C. A. Moskaluk, and S. M. Powell Allelotype of Gastric Adenocarcinoma Cancer Res., April 1, 1999; 59(7): 1437 - 1441. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Thangavelu, W. G. Finn, K. K. Yelavarthi, H. H. Roenigk Jr, E. Samuelson, L. Peterson, T. M. Kuzel, and S. T. Rosen Recurring Structural Chromosome Abnormalities in Peripheral Blood Lymphocytes of Patients With Mycosis Fungoides/Sezary Syndrome Blood, May 1, 1997; 89(9): 3371 - 3377. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Cell Growth & Differentiation |